:::

詳目顯示

回上一頁
題名:疑似Paclitaxel引起多形性紅斑(Erythema Multiforme)之案例報告
書刊名:臺灣臨床藥學雜誌
作者:李梅君王瑩玉劉惠文
作者(外文):Lee, Mai-junWang, Ying-yueLiu, Huei-wen
出版日期:2005
卷期:13:1
頁次:頁101-113
主題關鍵詞:多形性紅斑過敏反應前置給藥輸注時間PaclitaxelErythema multiformeHypersensitivity reactionHSRPremedicationInfusion rate
原始連結:連回原系統網址new window
相關次數:
  • 被引用次數被引用次數:期刊(0) 博士論文(0) 專書(0) 專書論文(0)
  • 排除自我引用排除自我引用:0
  • 共同引用共同引用:0
  • 點閱點閱:103
期刊論文
1.(2004)。DRUG CONSULTS: Taxanes-dose, infusion rate, and hypersensitivity under the title of Paxlitaxel。MICROMEDEX (R) Healthcare Series,119。  new window
2.Weinberg, J. M.、Egan, C.、Tangoren, I. A.、Li, L.、Laughinghouse, K. A.、Guzzo, C. A.(1997)。Generalized pustular dermatosis following paclitaxel therapy。Int J Dermatol,36,559-560。  new window
3.Young, P. C.、Montemarano, A. D.、Lee, N.、Sau, P.、Weiss, R. B.、James, W. D.(1996)。Hypersensitivity to paclitaxel manifested as a bullous fixed drug eruption。J Am Acad Dermatol,34,313-314。  new window
4.Roth, B. J.、Yeap, B. Y.、Wilding, G.、Kasimis, B.、McLeod, D.、Loehrer, P. J.(1993)。Taxol in advanced, hormone-refractory carcinoma of the prostate。Cancer,72,2457-2460。  new window
5.Peerboom, D. M.、Donehower, R. C.、Eisenhauer, E. A.(1993)。Successful re-treatment with Taxol after major hypersensitivity reactions。J Clin Oncol,11,885-890。  new window
6.Rayne, J. Y.、Holmes, F.、Cohen, P. R.、Gagel, R.(1996)。Severe mucocutaneous toxicity in a patient with hyperbilirubinemia。Southern Medical Journal,89(5),542-545。  new window
7.Beri, R. B.、Rosen, F. R.、Pacini, M. J.、Desai, S. R.(200402)。Severe dermatologic reactions at multiple sites after paclitaxel administration。The Annals of Pharmacotherapy,38,238-241。  new window
8.Laskin, M. S.、Lucchesi, K. J.、Morgan, M.(1993)。Paclitaxel rechallenge failure after a major hypersensity reaction。J Clin Oncol,11,2456-2457。  new window
9.Markman, M.(1997)。Simplified regiment for the prevention of paclitaxel-associated hypersensitivity reactions。Journal of Clinical Oncology,15,3517。  new window
10.Markman, M.(199907)。An effective and more convenient drug regimen for prophylaxis against paclitaxel-associated hypersensitivity reactions。J Cancer Res Clin Oncol,125(7),427-429。  new window
11.Bookman, M. A.(1997)。Short-course intravenous prophylaxis for paclitaxel-related hypersensitivity reactions。Ann Oncol,8(6),611-614。  new window
12.Koppler, H.、Heymanns, J.、Weide, R.(200106)。Dose reduction of steroid premedication for paclitaxel: no increase of hypersensitivity reactions。Onkologie,24(3),283-285。  new window
圖書
1.Mcevoy, G. K.(2004)。American Society of Health-system Pharmacists。  new window
2.(200106)。Package insert: Taxol (paclitaxel)。Miami, FL:IVAX Laboratories。  new window
3.Perry, M. C.、Weiss, R. B.。The Chemotherapy Sourcebook。  new window
4.Finley, R. S.、Balmer, C.。Concepts in Oncology Therapeutics。  new window
5.Dukes, M. N. G.、Aronson, J. K.(2000)。Meyler's Side Effects of Drugs。Amsterdam:Elsevier。  new window
6.Casciato, D. A.(2004)。Manual of Clinical Oncology。  new window
7.Chabner, B. A.(2001)。Cancer Chemotherapy & Biotherapy: Principles & Practices。  new window
8.Valley, A. W.、Balmer, C. M.(1985)。Pharmacotherapy。  new window
9.Rubin, S. C.(1996)。Chemotherapy of gynecologic cancers: Society of Gynecologic Oncologists handbook。  new window
 
 
 
 
第一頁 上一頁 下一頁 最後一頁 top
QR Code
QRCODE